Veterinary medicines European public assessment report (EPAR): Respivac TRT, Turkey rhinotracheitis virus, strain 1062, live, Status: Opinion

Annex II to the call for proposals - Vendor financial identification form

Product Management Service (PMS) Product UI and API training (access & navigation), Online, European Medicines Agency, Amsterdam, the Netherlands, from 3 June 2024, 10:00 (CEST) to 3 June 2024, 11:30 (CEST)

EMA multi-stakeholder workshop on psychedelics – Towards an EU regulatory framework, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 16 April 2024, 13:00 (CEST) to 17 April 2024, 16:00 (CEST)

Committee for Medicinal Products for Human Use (CHMP): 19-22 February 2024, European Medicines Agency, Amsterdam, the Netherlands, from 19 February 2024 to 22 February 2024

Human medicines European public assessment report (EPAR): Abiraterone Accord, abiraterone, Date of authorisation: 26/04/2021, Revision: 2, Status: Authorised

SPOR Status Update, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 10 July 2024, 10:00 (CEST) to 10 July 2024, 12:30 (CEST)

Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI)

Timetable: Safety signal - Assessment of responses to request for supplementary information (RSI) - ATMP

Timetable: Post-authorisation measure (PAM) Paediatric art. 46 submission - ATMP